Cardiovascular Clinical Trial - Tendyne - Summit

Cardiovascular

Status:

Open to accrual

ClinicalTrials.gov:

NCT04847557

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT) (SUMMIT)

Drug

Tirzepatide, Placebo

Condition

Obesity, Heart Failure With Preserved Ejection Fraction